Ivonne Haffner
0000-0002-7814-0367
University Medical Center
13 papers found
Refreshing results…
SAPHIR: real-world clinical research platform for molecular testing, treatment, and clinical and patient-reported outcomes in patients with gastroesophageal cancer in Germany
Supplementary Data from Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients
Data from Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients
Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study
Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients
Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies—the role of HAS2, SHB and HBEGF
Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer
HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study
Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines
Towards Phenotyping of Clinical Trial Eligibility Criteria.
Regulation of arginase-1 expression in macrophages by a protein kinase a type I and histone deacetylase dependent pathway
STATINS REDUCE MACROPHAGE INFLAMMATORY PROTEIN‐1α EXPRESSION IN HUMAN ACTIVATED MONOCYTES
Identification of Macrophage Arginase I as a New Candidate Gene of Atherosclerosis Resistance
Missing publications? Search for publications with a matching author name.